期刊文献+

喷雾干燥法制备1型糖尿病反义肽噬菌体壳聚糖微球疫苗 被引量:3

Preparation of Bacteriophage-Displayed Diabete Type 1 Vaccine in Chitosan Microspheres by Spray Drying
原文传递
导出
摘要 目的制备1型糖尿病反义肽噬菌体壳聚糖微球疫苗,并观察其热稳定性。方法采用水溶性壳聚糖、海藻糖、甘氨酸作为保护剂,通过喷雾干燥技术制备1型糖尿病反义肽噬菌体壳聚糖微球疫苗,扫描电镜下观察其形态及粒径大小,并检测入口温度及海藻糖浓度对壳聚糖微球疫苗活性的影响。将喷雾干燥样品置37℃放置6d,检测其热稳定性。结果通过喷雾干燥法制备的1型糖尿病反义肽噬菌体壳聚糖微球疫苗电镜下呈不规则的球形,粒径大小为20μm左右。喷雾干燥后样品的滴度与喷雾干燥前的疫苗原液相比均降低,且随着入口温度的升高而先升高后降低;喷雾干燥后的样品随着海藻糖浓度的增加,滴度也相应升高。与喷雾干燥前的疫苗原液相比,壳聚糖微球疫苗具有更好的热稳定性。结论已成功制备了1型糖尿病反义肽噬菌体壳聚糖微球疫苗,其具有良好的热稳定性。 Objective To prepare bacteriophage-displayed diabete type 1 vaccine in chitosan microspheres and observe its thermal stability. Methods Bacteriophage-displayed diabete type 1 vaccine in chitosan microspheres was prepared by spray drying using a protective agent composed of water-soluble chitosan, trehalose and glycine, then observed for shape and size by scanning electron microscopy. The effects of inlet temperature and trehalose concentration on activity of the prepared microsphere vaccine were observed. The vaccine sample after spray drying was stored at 37℃ for 6 d and observed for thermal stability. Results The prepared vaccine was in shape of irregular spheres at a mean size of about 20 μm under scanning electron microscope. The titer of vaccine af- ter spray drying was lower than that of bulk before spray drying, and increased with the increasing inlet temperature then decreased. However, the titer of vaccine sample after spray drying increased with the increasing trehalose concentration. Compared with the bulk before spray drying, the microsphere vaccine showed good thermal stability. Conclusion Bacteriophage-displayed diabete type 1 vaccine in chitosan microspheres was successfully prepared and showed good thermal stability.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第5期480-482,共3页 Chinese Journal of Biologicals
基金 国家863项目"预防性1型糖尿病反义肽抗原的中试和临床前研究"(2006AA02Z4C0) 云南省科技厅攻关项目"噬菌体展示新型疫苗技术平台的建立及其在1型糖尿病反义肽疫苗研制中的应用"(2006SG05)
关键词 1型糖尿病疫苗 喷雾干燥 壳聚糖微球 保护剂 Diabete type 1 vaccine Spray drying Chitosan microspheres Protective agent
  • 相关文献

参考文献8

  • 1Corbanie EA, Remon JP, Yan Reeth K, et al. Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry. Vaccine, 2007, 25 (49): 8306 -8317.
  • 2Eldridge JH, Hammond C J, Meulbroek JA, et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release, 1990, 11 ( 1-3 ): 205-214.
  • 3Chew JL, Wotfowicz CB, Mao HQ, et al. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der pl for oral vaccination in mice. Vaccine, 2003, 21 (21-22): 2720- 2729.
  • 4曹俊,周南进.壳聚糖抗肿瘤作用的研究进展[J].中国生化药物杂志,2005,26(2):126-127. 被引量:25
  • 5Seferian PG, Martinez ML. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine, 2001, 19(6): 661-668.
  • 6Murata Y, Toniwa S, Miyamoto E, et al. Preparation of alginate gel beads containing chitosan salt and their function. Int J Pharos, 1999, 176(2): 265-268.
  • 7龚燕锋,谢勇.免疫佐剂与壳聚糖[J].中国生化药物杂志,2004,25(6):374-376. 被引量:7
  • 8向艳,杨红.壳聚糖在药物缓释载体中的应用[J].中国生化药物杂志,2005,26(1):62-64. 被引量:24

二级参考文献60

  • 1沈江波 林建立 张世馥.壳聚糖对人子宫颈癌HeLa细胞生长作用的研究.解剖学报,1997,28(4):421-421.
  • 2Felt O, Buri P, Gumy R. Chitosan: a unique polysaccharide for drug delivery [ J]. Drug Dev Ind Pharm, 1998,24( 11 ) :979-993.
  • 3Felt O, Furrer P, Mayer JM, et al. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention[J]. Int J Pharm, 1999,180 (2): 185-193.
  • 4Ohya Y, Takei T, Kobayashi H, et al. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition[J]. J Microencapsul, 1993,10( 1 ): 1-9.
  • 5Mi FL, Wu YB, Shyu SS, et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery [J]. J Biomed Mater Res,2002,59(3) :438-449.
  • 6Yusof NL, Wee A, Lim LY, et al Flexible chitin films as potential wound-dressing materials: wound model studies [ J]. J Biomed Mater Res, 2003,66A (2): 224-232.
  • 7Pan Y,Li YJ,Zhao HY, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo[J]. Int J Pharm,2002,249(1-2) :139-147.
  • 8He P, Davis SS, Illum L. Sustained release chitosan microspheres prepared by novel spray drying methods [ J ]. J Microencapsul, 1999, 16(3) :343-345.
  • 9Tozaki H, Odoriba T, Okada N, et al. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylie acid in the large intestine accelerates healing of TNBS-indueed colitis in rats[J]. J Control Release, 2002,82 ( 1 ): 51-61.
  • 10Tapia C, Costa E, Moris M, et al. Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate [J]. Drug Dev Ind Pharm, 2002,28(2) :217-224.

共引文献48

同被引文献20

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部